Biomaterials and surgical techniques for reconstructive tympanic membrane (TM) surgery are under development. Tympanoplasty, the mainstay for TM reconstruction, was first described in 1952 by Wullstein and Zöllner (
1-
4). Historically, various materials, including autogenous, allogenous, and exogenous grafts, as well as various alternative methods for surgical repair, have been used for TM reconstruction. Today, tympanoplasty with temporalis muscle fascia is the most commonly used method, boasting a success rate of 70 - 90% (
5-
7).
Temporalis muscle fascia has several advantages that make it an ideal choice for TM perforation grafting: It is readily available in the operative field, provides stable results for TM reconstruction, and has ideal handling properties (
8). The need for more rigid grafting, particularly in patients with eustachian tube dysfunction and severe TM retraction, has led to the use of cartilage grafts (
2). Although cartilage grafts have proven to be a suitable alternative to temporalis muscle fascia grafts, potential hearing loss remains a concern (
7). Additionally, the most common region of graft failure is the anterior superior part due to weak graft support and poor vascularity (
9). Therefore, in cases of anterior perforation, fascia can be supported by adding a cartilage graft medial to it. While cartilage strengthens the fascia and prevents retraction formation, there is concern about impairing the vibratory properties of the TM.
Moreover, a review of studies on cartilage reinforcement techniques revealed conflicting findings. The literature on the results of cartilage-fascia tympanoplasty in anterior perforations is also scarce. This overview describes cartilage-fascia tympanoplasty as a new reconstructive method and evaluates the success rates and outcomes of this novel technique compared to traditional fascia tympanoplasty in anterior TM perforation.